Benjamin Bouillet

2.7k total citations
95 papers, 1.8k citations indexed

About

Benjamin Bouillet is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Benjamin Bouillet has authored 95 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Endocrinology, Diabetes and Metabolism, 32 papers in Surgery and 31 papers in Epidemiology. Recurrent topics in Benjamin Bouillet's work include Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Liver Disease Diagnosis and Treatment (19 papers) and Diabetes Treatment and Management (18 papers). Benjamin Bouillet is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Liver Disease Diagnosis and Treatment (19 papers) and Diabetes Treatment and Management (18 papers). Benjamin Bouillet collaborates with scholars based in France, Italy and United Kingdom. Benjamin Bouillet's co-authors include Bruno Vergès, Laurence Duvillard, Jean‐Michel Petit, Damien Denimal, Romaric Loffroy, Alexia Rouland, Jean–Pierre Cercueil, Patrick Hillon, Jean-Paul Paı̈s de Barros and M.-C. Brindisi and has published in prestigious journals such as Endocrine Reviews, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Benjamin Bouillet

88 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Bouillet France 24 966 793 567 310 260 95 1.8k
Alan Jaap United Kingdom 19 667 0.7× 293 0.4× 333 0.6× 103 0.3× 269 1.0× 43 1.4k
Hong Tao China 20 506 0.5× 437 0.6× 262 0.5× 340 1.1× 293 1.1× 46 1.5k
Jonathan Hazlehurst United Kingdom 19 1.8k 1.8× 2.2k 2.7× 642 1.1× 654 2.1× 238 0.9× 43 3.1k
Alper Gürlek Türkiye 21 700 0.7× 379 0.5× 351 0.6× 146 0.5× 114 0.4× 48 1.3k
Andromachi Vryonidou Greece 22 805 0.8× 293 0.4× 339 0.6× 292 0.9× 283 1.1× 67 1.9k
Serkan Tapan Türkiye 25 367 0.4× 486 0.6× 326 0.6× 285 0.9× 314 1.2× 81 1.5k
Kohzo Takebayashi Japan 24 630 0.7× 704 0.9× 306 0.5× 522 1.7× 472 1.8× 78 2.0k
Hazem Elariny United States 18 461 0.5× 1.1k 1.4× 298 0.5× 229 0.7× 256 1.0× 26 1.5k
Angela Criscimanna Italy 16 856 0.9× 538 0.7× 440 0.8× 330 1.1× 414 1.6× 23 2.0k
Miyase Bayraktar Türkiye 20 333 0.3× 185 0.2× 192 0.3× 179 0.6× 54 0.2× 43 1.0k

Countries citing papers authored by Benjamin Bouillet

Since Specialization
Citations

This map shows the geographic impact of Benjamin Bouillet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Bouillet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Bouillet more than expected).

Fields of papers citing papers by Benjamin Bouillet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Bouillet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Bouillet. The network helps show where Benjamin Bouillet may publish in the future.

Co-authorship network of co-authors of Benjamin Bouillet

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Bouillet. A scholar is included among the top collaborators of Benjamin Bouillet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Bouillet. Benjamin Bouillet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walker, Paul M., Isabelle Fournel, Alexandre Cochet, et al.. (2025). Evolution of myocardial steatosis in high cardiovascular risk T2DM patients treated by GLP1 receptor agonists: LICAS study. Diabetes Research and Clinical Practice. 221. 112017–112017. 1 indexed citations
2.
Boustani, Jihane, et al.. (2024). Management of Graves’ ophthalmopathy by radiotherapy: A literature review. Cancer/Radiothérapie. 28(3). 282–289. 2 indexed citations
3.
Rouland, Alexia, Thomas Gautier, Damien Denimal, et al.. (2024). The Endogenous Inhibitor of CETP, apoC1, Remains Ineffective In Vivo after Correction of Hyperglycemia in People with Type 1 Diabetes. Metabolites. 14(9). 487–487.
4.
Van, Georges Ha, Sophie Schuldiner, Ariane Sultan, et al.. (2023). Use of the SINBAD score as a predicting tool for major adverse foot events in patients with diabetic foot ulcer: A French multicentre study. Diabetes/Metabolism Research and Reviews. 39(8). e3705–e3705. 3 indexed citations
5.
Meloni, Marco, Benjamin Bouillet, Raju Ahluwalia, et al.. (2023). Validation of the Fast-Track Model: A Simple Tool to Assess the Severity of Diabetic Foot Ulcers. Journal of Clinical Medicine. 12(3). 761–761. 6 indexed citations
6.
Denimal, Damien, Serge Monier, Benjamin Bouillet, Bruno Vergès, & Laurence Duvillard. (2023). High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity. Metabolites. 13(2). 253–253. 24 indexed citations
7.
8.
Denimal, Damien, Serge Monier, Isabelle Simoneau, et al.. (2022). Normal HDL Cholesterol Efflux and Anti-Inflammatory Capacities in Type 2 Diabetes Despite Lipidomic Abnormalities. The Journal of Clinical Endocrinology & Metabolism. 107(9). e3816–e3823. 17 indexed citations
9.
10.
Denimal, Damien, Serge Monier, Isabelle Simoneau, et al.. (2022). HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control. Cardiovascular Diabetology. 21(1). 154–154. 7 indexed citations
11.
12.
Vergès, Bruno, Laurence Duvillard, Jean-Paul Paı̈s de Barros, et al.. (2021). Liraglutide Increases the Catabolism of Apolipoprotein B100–Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression. Diabetes Care. 44(4). 1027–1037. 32 indexed citations
13.
Rouland, Alexia, et al.. (2021). Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion. Clinical Pharmacology Advances and Applications. Volume 13. 33–37. 3 indexed citations
14.
Vergès, Bruno, Jean‐Michel Petit, Isabelle Simoneau, et al.. (2021). Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer. Diabetes & Metabolism. 47(6). 101245–101245. 4 indexed citations
15.
Vergès, Bruno, Alexia Rouland, Benjamin Bouillet, et al.. (2021). Liraglutide reduces plasma PCSK9 in patients with type 2 diabetes not treated with statins. Diabetes & Metabolism. 48(2). 101284–101284. 7 indexed citations
16.
Vergès, Bruno, Alexia Rouland, S. Baillot-Rudoni, et al.. (2020). Increased body fat mass reduces the association between fructosamine and glycated hemoglobin in obese type 2 diabetes patients. Journal of Diabetes Investigation. 12(4). 619–624. 5 indexed citations
17.
Wargny, Matthieu, Pierre‐Henri Ducluzeau, Jean‐Michel Petit, et al.. (2018). Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population. Atherosclerosis. 278. 82–90. 32 indexed citations
18.
Laurent, Camille, Olivier Casasnovas, Laurent Martin, et al.. (2016). Adrenal lymphoma: presentation, management and prognosis. QJM. 110(2). hcw174–hcw174. 47 indexed citations
19.
Denimal, Damien, Jean-Paul Paı̈s de Barros, Jean‐Michel Petit, et al.. (2015). Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration. Atherosclerosis. 241(2). 752–760. 48 indexed citations
20.
Nourissat, Geoffroy, et al.. (2014). Optimization of bone-block positioning in the Bristow-Latarjet procedure: A biomechanical study. Orthopaedics & Traumatology Surgery & Research. 100(5). 509–513. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan Jaap Breakdown of academic impact, for papers by Hong Tao Breakdown of academic impact, for papers by Jonathan Hazlehurst Breakdown of academic impact, for papers by Alper Gürlek Breakdown of academic impact, for papers by Andromachi Vryonidou Breakdown of academic impact, for papers by Serkan Tapan Breakdown of academic impact, for papers by Kohzo Takebayashi Breakdown of academic impact, for papers by Hazem Elariny Breakdown of academic impact, for papers by Angela Criscimanna Breakdown of academic impact, for papers by Miyase Bayraktar
Rankless by CCL
2026